An Open-Label, Dose-Escalating Phase 1 Safety Study of HibmLT Vaccine in Healthy Volunteers (I)

2013-05-012024-05-14https://scholars.lib.ntu.edu.tw/handle/123456789/657100b 型嗜血桿菌疫苗新接合蛋白多醣臨床一期試驗HibmLT VaccineLTh(αK)PRP (Polyribosyl-ribitol phosphate)Phase 1 clinical trialAn Open-Label, Dose-Escalating Phase 1 Safety Study of HibmLT Vaccine in Healthy Volunteers (I)